physIQ Promotes Chris Economos to Senior VP, Corporate Development

physIQ is revamping its top leadership team.

The company promoted Chief Commercial Officer Chris Economos to senior vice president, corporate development, and hired Michael Petrarca as senior vice president and general manager, life sciences. The pair will focus on expanding physIQ’s strategic partnerships and providing value and quality solutions to healthcare and life sciences organizations worldwide.

Economos joined physIQ in 2014 and has steadily grown in his roles. Historically, Economos’ work at physIQ has included spearheading go-to-market strategy, marketing, and sales. In his new role, Economos will serve as a pivotal leader in the growth and development of the organization, including overseeing corporate partnerships, M&A activities, and innovation to extend market leadership and grow enterprise value. Before joining physIQ, Economos led and worked at organizations such as Healthy Interactions and AbbVie. 

Economos earned a bachelor of science degree from Vanderbilt University and an MBA from the Indiana University Kelley School of Business.
 
“Our company and the market are at a point of maturity where we need to think about the next level,” said Economos. “The opportunity related to AI and biosensors is at a point where we need to focus on the strategic moves necessary to extend our leadership position in the market. I’m thrilled to move into this new role, which will allow me to execute on the big-picture initiatives that will enable us to realize our transformational vision.” 
 
Petrarca brings more than 30 years of experience in the life sciences industry to his new role. He will act as both leader and mentor, growing physIQ’s sales and customer care team and direct and oversee the vision and growth of the life sciences practice, while also maintaining existing client relationships and partnerships.
 
Petrarca’s background and expertise in ensuring operational and commercial success is expected to help drive physIQ’s growth, building out the sales pipeline and ensuring client success. His previous roles include executive leadership, consulting and sales positions at life sciences and biopharmaceutical organizations such as Pfizer, Medidata and Clarivate.

Petrarca earned a bachelor of science degree in biochemistry from Trinity College and is a retired U.S. Naval Officer.
 
“In many ways, this role is what I’ve been working towards throughout my career,” said Petrarca. “I was immediately drawn to the promise and innovation that is taking place at physIQ, and it was clear that no other company compares with respect to the technical foundation and market reputation. I am excited and honored to work with the physIQ team to cut through the noise in the life sciences continuum, ultimately addressing what really matters, which is speeding the process of getting life-saving medications to patients, faster.”
 
“Through this period of aggressive growth, our organization has the opportunity to scale both quickly and smartly,” said Gary Conkright, physIQ CEO, director and co-founder. “Chris is a foundational member of our team and, with his deep understanding of the market, where it’s going, and our unrivaled technology, he is ideally positioned to ensure we have the right assets and partnerships in place to achieve our vision. Meanwhile, Michael has touched virtually every aspect of the life sciences industry and has already provided valuable insights to our organization. Together, Chris and Michael bring a crucial combination of strategic expertise that will help physIQ expand even further.”

PhysIQ is the leader in digital medicine, dedicated to generating health insight using continuous wearable biosensor data and advanced analytics. Its enterprise-ready cloud platform continuously collects and processes data from any wearable biosensor using a deep portfolio of FDA-cleared analytics. The company has published one of the most rigorous clinical studies to date in digital medicine and develops, validates, and achieves regulatory approval of artificial intelligence-based analytics.